CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 13 enrolled
Drug / intervention
Bosentan +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02667704
NCT02667704Phase 1Completed
CompareCT.gov

Influence of Bosentan on the Pharmacokinetics of Nintedanib in Healthy Male Subjects

Boehringer Ingelheim·interventional·Posted Jan 29, 2016·Updated Apr 13, 2017

In Brief

A Phase 1 clinical trial evaluating Bosentan and Nintedanib for Healthy. Completed, enrolled 13 participants across 1 site.

Detailed Summary

The trial was designed to investigate whether, and to which extent, multiple doses of bosentan may influence the plasma levels of nintedanib administered as a single dose.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--

Timeline

Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 29, 2016
Enrollment StartFeb 1, 2016
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.4 years ago

Interventions

Bosentandrug

Nintedanibdrug